Tune Therapeutics Presents First Data Supporting TUNE-401: a First-in-Class Epigenetic Silencer for Hepatitis B
Tune Therapeutics is a Duke start-up and DCP portfolio company developing epigenetic editing spun out of the lab of co-founder Professor Charles Gersbach (BME, Pratt).
Invented at Duke 2023 – Engineering highlights
The Pratt School of Engineering was a big participant in the 5th Annual Invented at Duke, with multiple inventors and resources. Watch the video here.
NexJ Health & ZealCare to Deliver Next Generation Behavior Change Solutions for Disease Management and Health Enhancement
ZealCare is a personalized health coaching platform start-up co-founded by Chancellor Emeritus Dr. Ralph Snyderman (DOM, SOM) and Assistant Professor Connor Drake (Population Health, SOM) based on tech developed at the Duke Center for Personalized…
Invented at Duke 2023 showcases a bustling innovation ecosystem
Featuring inventor booths, innovation resources, and strong support in speeches from leaders, Invented at Duke 2023 caps a big year for OTC.
Can nanosensor technology and stem cell transplants revolutionise type 1 diabetes treatment? – Diabetes Voice
Minutia is a next generation cell therapy start-up co-founded by cell sensing luminary Professor Tuan Vo-Dinh (BME, Pratt).
New Analyses from Pivotal Phase 3 INDIGO Study Reinforce Vorasidenib’s Potential to Change the Treatment Paradigm for IDH-Mutant Diffuse Glioma
This application of vorasidenib is based on licensed technology developed by Dr. Darell Bigner (Neurobiology, SOM) and colleagues.
Duke Spinoff Tyrata Acquired by Bridgestone
A tire tech startup hatched at Duke Engineering has fully fledged the nest to become part of one of the world’s largest tire manufacturers.
BMI OrganBank™ Selected by the North Carolina Biotechnology Center for Funding to Advance Medical Device
NOTE: BMI OrganBank licensed perfusion tech from the Duke Ex-Vivo Organ Lab, led by Drs. Andrew S. Barbas and Matthew Hartwig (Surgery, SOM).
Duke Inventions Returned $102 Million to Inventors and the University in FY23
Fifteen new companies and expanded capacity for Office for Translation & Commercialization showcased in the FY23 annual report.